<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 11, 2026 at 1:40 PM by All in One SEO v4.9.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Fri, 10 Apr 2026 10:27:38 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/vanda-urges-fda-to-reject-extended-drug-review-timelines/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/vanda-urges-fda-to-reject-extended-drug-review-timelines/]]></link>
			<title>Vanda Urges FDA to Reject Extended Drug Review Timelines</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:27:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/jazz-pharmaceuticals-presents-neurology-drug-data-at-aan/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/jazz-pharmaceuticals-presents-neurology-drug-data-at-aan/]]></link>
			<title>Jazz Pharmaceuticals Presents Neurology Drug Data at AAN</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:21:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/innovent-showcases-tri-specific-autoimmune-therapy-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/innovent-showcases-tri-specific-autoimmune-therapy-data/]]></link>
			<title>Innovent Showcases Tri-Specific Autoimmune Therapy Data</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:15:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/heartfocus-inteleos-launch-ai-cardiac-pocus-certification/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/heartfocus-inteleos-launch-ai-cardiac-pocus-certification/]]></link>
			<title>HeartFocus, Inteleos Launch AI Cardiac POCUS Certification</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:09:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/cosmetics/revision-skincare-validates-vitamin-c-serum-in-clinical-studies/]]></guid>
			<link><![CDATA[https://cgxpwire.com/cosmetics/revision-skincare-validates-vitamin-c-serum-in-clinical-studies/]]></link>
			<title>Revision Skincare Validates Vitamin C Serum in Clinical Studies</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:57:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/dualitybio-advances-her2-adc-toward-china-approval/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/dualitybio-advances-her2-adc-toward-china-approval/]]></link>
			<title>DualityBio Advances HER2 ADC Toward China Approval</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:47:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/difgen-apotex-win-fda-approval-for-nintedanib-capsules/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/difgen-apotex-win-fda-approval-for-nintedanib-capsules/]]></link>
			<title>DifGen, Apotex Win FDA Approval for Nintedanib Capsules</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:24:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/veterinary/boehringer-supports-ecuador-rabies-elimination-program/]]></guid>
			<link><![CDATA[https://cgxpwire.com/veterinary/boehringer-supports-ecuador-rabies-elimination-program/]]></link>
			<title>Boehringer Supports Ecuador Rabies Elimination Program</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:12:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/food/iherb-expands-global-reach-with-kylie-jenner-k2o-launch/]]></guid>
			<link><![CDATA[https://cgxpwire.com/food/iherb-expands-global-reach-with-kylie-jenner-k2o-launch/]]></link>
			<title>iHerb Expands Global Reach with Kylie Jenner k2o Launch</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:06:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/alivecor-expands-ai-cardiac-ecg-technology-in-vietnam/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/alivecor-expands-ai-cardiac-ecg-technology-in-vietnam/]]></link>
			<title>AliveCor Expands AI Cardiac ECG Technology in Vietnam</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 08:58:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/boehringer-advances-novel-combo-therapy-in-sclc-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/boehringer-advances-novel-combo-therapy-in-sclc-trial/]]></link>
			<title>Boehringer Advances Novel Combo Therapy in SCLC Trial</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 08:50:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/c4-and-roche-expand-dac-cancer-drug-collaboration/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/c4-and-roche-expand-dac-cancer-drug-collaboration/]]></link>
			<title>C4 and Roche Expand DAC Cancer Drug Collaboration</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 08:45:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/alpheus-medical-starts-phase-2b-trial-in-glioblastoma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/alpheus-medical-starts-phase-2b-trial-in-glioblastoma/]]></link>
			<title>Alpheus Medical Starts Phase 2b Trial in Glioblastoma</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 06:57:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/glenmark-pharmaceuticals-gains-fda-nod-for-progesterone/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/glenmark-pharmaceuticals-gains-fda-nod-for-progesterone/]]></link>
			<title>Glenmark Pharmaceuticals Gains FDA Nod for Progesterone</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 05:55:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/oricell-therapeutics-secures-110m-for-car-t-expansion/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/oricell-therapeutics-secures-110m-for-car-t-expansion/]]></link>
			<title>Oricell Therapeutics Secures $110M for CAR-T Expansion</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 05:32:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/decoy-therapeutics-advances-ai-antiviral-pipeline-fast/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/decoy-therapeutics-advances-ai-antiviral-pipeline-fast/]]></link>
			<title>Decoy Therapeutics Advances AI Antiviral Pipeline Fast</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 05:06:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/lilly-launches-foundayo-oral-glp-1-weight-loss-drug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/lilly-launches-foundayo-oral-glp-1-weight-loss-drug/]]></link>
			<title>Lilly Launches Foundayo Oral GLP-1 Weight Loss Drug</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 04:44:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/waters-wins-fda-clearance-for-at-home-hpv-cancer-test/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/waters-wins-fda-clearance-for-at-home-hpv-cancer-test/]]></link>
			<title>Waters Wins FDA Clearance for At-Home HPV Cancer Test</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 17:53:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/vedanta-biosciences-advances-microbiome-drugs-at-escmid-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/vedanta-biosciences-advances-microbiome-drugs-at-escmid-2026/]]></link>
			<title>Vedanta Biosciences Advances Microbiome Drugs at ESCMID 2026</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:35:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/arkbio-advances-ak0406-phase-i-trial-for-influenza/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/arkbio-advances-ak0406-phase-i-trial-for-influenza/]]></link>
			<title>ArkBio Advances AK0406 Phase I Trial for Influenza</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 04:25:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/biocon-launches-denosumab-biosimilars-in-u-s/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/biocon-launches-denosumab-biosimilars-in-u-s/]]></link>
			<title>Biocon Launches Denosumab Biosimilars in U.S.</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 10:27:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/bioora-and-octane-expand-car-t-manufacturing-globally/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/bioora-and-octane-expand-car-t-manufacturing-globally/]]></link>
			<title>BioOra and Octane Expand CAR-T Manufacturing Globally</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 09:32:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/vanda-initiates-thetis-trial-for-glp-1-vomiting-prevention/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/vanda-initiates-thetis-trial-for-glp-1-vomiting-prevention/]]></link>
			<title>Vanda Initiates Thetis Trial for GLP-1 Vomiting Prevention</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 17:45:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/garda-to-acquire-assertio-in-125m-pharma-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/garda-to-acquire-assertio-in-125m-pharma-deal/]]></link>
			<title>Garda to Acquire Assertio in $125M Pharma Deal</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 10:19:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/immutrin-raises-87m-to-advance-amyloidosis-antibody-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/immutrin-raises-87m-to-advance-amyloidosis-antibody-therapy/]]></link>
			<title>Immutrin Raises $87M to Advance Amyloidosis Antibody Therapy</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:25:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/memorialcare-joins-fastest-trial-for-stroke-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/memorialcare-joins-fastest-trial-for-stroke-therapy/]]></link>
			<title>MemorialCare Joins FASTEST Trial for Stroke Therapy</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:19:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/avista-acquires-bentec-to-expand-medtech-manufacturing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/avista-acquires-bentec-to-expand-medtech-manufacturing/]]></link>
			<title>Avista Healthcare Partners Acquires Bentec to Expand MedTech Manufacturing</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:07:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/phanes-advances-spevatamig-to-expansion-in-btc-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/phanes-advances-spevatamig-to-expansion-in-btc-trial/]]></link>
			<title>Phanes Advances Spevatamig to Expansion in BTC Trial</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:06:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/anumana-gains-fda-clearance-for-ecg-ai-amyloidosis-tool/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/anumana-gains-fda-clearance-for-ecg-ai-amyloidosis-tool/]]></link>
			<title>Anumana Gains FDA Clearance for ECG-AI Amyloidosis Tool</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/saladax-expands-global-access-to-drug-monitoring-tests/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/saladax-expands-global-access-to-drug-monitoring-tests/]]></link>
			<title>Saladax Expands Global Access to Drug Monitoring Tests</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 08:54:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/insmed-cedar-study-misses-endpoints-in-hs-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/insmed-cedar-study-misses-endpoints-in-hs-trial/]]></link>
			<title>Insmed CEDAR Study Misses Endpoints in HS Trial</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 08:46:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/alloy-and-biogen-partner-on-antisense-drug-platform/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/alloy-and-biogen-partner-on-antisense-drug-platform/]]></link>
			<title>Alloy and Biogen Partner on Antisense Drug Platform</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 09:15:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/gsk-secures-china-approval-for-exdensur-in-nasal-polyps-treatment/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/gsk-secures-china-approval-for-exdensur-in-nasal-polyps-treatment/]]></link>
			<title>GSK Secures China Approval for Exdensur in Nasal Polyps Treatment</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:18:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/nuvalent-submits-nda-for-neladalkib-in-alk-lung-cancer/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/nuvalent-submits-nda-for-neladalkib-in-alk-lung-cancer/]]></link>
			<title>Nuvalent Submits NDA for Neladalkib in ALK Lung Cancer</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 08:38:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/lupin-gains-us-fda-nod-for-dapagliflozin-tablets/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/lupin-gains-us-fda-nod-for-dapagliflozin-tablets/]]></link>
			<title>Lupin Gains US FDA Nod for Dapagliflozin Tablets</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 08:34:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/supira-medical-gains-fda-nod-for-support-ii-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/supira-medical-gains-fda-nod-for-support-ii-trial/]]></link>
			<title>Supira Medical Gains FDA Nod for SUPPORT II Trial</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 08:21:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/lumonus-and-msk-advance-ai-radiation-planning/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/lumonus-and-msk-advance-ai-radiation-planning/]]></link>
			<title>Lumonus and MSK Advance AI Radiation Planning</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 09:03:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/dyno-ai-capsid-licensed-by-astellas-for-gene-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/dyno-ai-capsid-licensed-by-astellas-for-gene-therapy/]]></link>
			<title>Dyno AI Capsid Licensed by Astellas for Gene Therapy</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 10:57:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/resolve-and-pasteur-advance-cfrna-autoimmune-research/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/resolve-and-pasteur-advance-cfrna-autoimmune-research/]]></link>
			<title>Resolve and Pasteur Advance cfRNA Autoimmune Research</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:42:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/bioaffinity-showcases-cypath-lung-at-cleveland-clinic/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/bioaffinity-showcases-cypath-lung-at-cleveland-clinic/]]></link>
			<title>bioAffinity Showcases CyPath Lung at Cleveland Clinic</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:33:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/johnson-johnson-launches-varipulse-pro-in-europe/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/johnson-johnson-launches-varipulse-pro-in-europe/]]></link>
			<title>Johnson &amp; Johnson Launches VARIPULSE Pro in Europe</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:28:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/apotex-wins-approval-for-denoza-biosimilar-in-canada/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/apotex-wins-approval-for-denoza-biosimilar-in-canada/]]></link>
			<title>Apotex Wins Approval for DENOZA Biosimilar in Canada</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:22:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/singlomics-doses-first-patient-in-dxp-106-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/singlomics-doses-first-patient-in-dxp-106-trial/]]></link>
			<title>Singlomics Doses First Patient in DXP-106 Trial</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:00:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/fortrea-launches-ai-powered-fit-platform-to-transform-clinical-trials/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/fortrea-launches-ai-powered-fit-platform-to-transform-clinical-trials/]]></link>
			<title>Fortrea Launches AI-Powered FIT Platform to Transform Clinical Trials</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:48:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/nanoviricides-files-measles-drug-for-rare-disease-status/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/nanoviricides-files-measles-drug-for-rare-disease-status/]]></link>
			<title>NanoViricides Files Measles Drug for Rare Disease Status</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 07:51:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/fortitude-advances-t-cell-therapy-for-axial-disease/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/fortitude-advances-t-cell-therapy-for-axial-disease/]]></link>
			<title>Fortitude Advances T-Cell Therapy for Axial Disease</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 07:43:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/merit-medical-acquires-view-point-to-expand-oncology-devices/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/merit-medical-acquires-view-point-to-expand-oncology-devices/]]></link>
			<title>Merit Medical Acquires View Point to Expand Oncology Devices</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:34:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/gilead-acquires-tubulis-to-boost-oncology-pipeline/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/gilead-acquires-tubulis-to-boost-oncology-pipeline/]]></link>
			<title>Gilead Acquires Tubulis to Boost Oncology Pipeline</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 07:34:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/als-research-at-risk-from-proposed-fy27-budget-cuts/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/als-research-at-risk-from-proposed-fy27-budget-cuts/]]></link>
			<title>ALS Research at Risk from Proposed FY27 Budget Cuts</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 06:55:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/emergent-expands-narcan-supply-in-bc-opioid-program/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/emergent-expands-narcan-supply-in-bc-opioid-program/]]></link>
			<title>Emergent Expands NARCAN Supply in BC Opioid Program</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:48:25 +0000]]></pubDate>
		</item>
				</channel>
</rss>
